Why This Is Important:
BMI is one of the main factors in determining eligibility for GLP-1 medications. A BMI of 30 or 25–29.9 + with health conditions often qualifies.

Why This Is Important:
These are strict FDA-listed contraindications to GLP-1 medications and require medical exclusion.

Known Weight-Related Comorbidities:

Type 2 Diabetes

High Blood Pressure

High Cholesterol

Cardiovascular Disease

Sleep Apnea

Osteoarthritis

Fatty Liver Disease

GERD

PCOS

Metabolic Syndrome

Chronic Kidney Disease

Depression or Anxiety